[Mitogen-activated protein kinases in atherosclerosis].

Area of Science:

• Cellular biology
• Molecular biology
• Pathophysiology

Background:

• Mitogen-activated protein (MAP) kinases mediate cellular responses to external stimuli.
• MAP kinases, including ERK1/2, JNK, and p38 MAPK, regulate diverse cellular functions.
• Emerging evidence implicates MAP kinases in the pathogenesis of atherosclerosis.

Purpose of the Study:

• To review current knowledge on MAP kinase-dependent mechanisms in atherosclerosis.
• To explore the role of MAP kinases in key atherosclerotic processes.
• To discuss the therapeutic potential of targeting MAP kinases in atherosclerosis.

Main Methods:

• Literature review of basic scientific studies.
• Analysis of research on MAP kinase pathways.
• Synthesis of findings on MAP kinase involvement in atherosclerosis.

Main Results:

• MAP kinases regulate inflammatory processes, endothelial cell activation, and immune cell function in atherosclerosis.
• MAP kinases are involved in smooth muscle cell proliferation and T-lymphocyte differentiation.
• Specific MAP kinase pathways are implicated in the development and progression of atherosclerotic plaques.

Conclusions:

• MAP kinases are critical mediators of cellular and molecular mechanisms in atherosclerosis.
• Targeting specific MAP kinases presents a potential therapeutic avenue for attenuating atherosclerotic plaque formation.
• Further research into MAP kinase signaling pathways is warranted for novel treatment strategies.